WNS - Q2 2025

Executive Summary

• Fiscal Q2 2025 revenue was $322.6M (-3.4% YoY; -0.2% QoQ) and net revenue (revenue less repair payments) was $310.7M (-4.4% YoY; -0.6% QoQ). Adjusted diluted EPS was $1.13 (+2.7% YoY; +21.5% QoQ), while GAAP diluted EPS was $0.92; EPS was above company forecast due to a one-time tax benefit (~$9M) and contingent consideration reversal. Guidance was cut and large-deal revenue was removed from FY25 projections.
• Adjusted operating margin was 18.6% (vs. 21.5% a year ago; 18.4% last quarter). Management expects margin expansion into the low 20s by Q4 FY25 as volumes recover and operating leverage improves.
• Guidance change: revenue less repair payments reduced to $1.250B–$1.296B (from $1.290B–$1.354B), ANI to $190M–$200M (from $203M–$215M), and adjusted diluted EPS to $4.13–$4.35 (from $4.42–$4.68). Capex held “up to $65M.” FX assumptions updated (GBP/USD 1.31; USD/INR 83.5).
• Stock narrative catalysts: the removal of large-deal revenue from guidance and continued OTA volume pressure create near-term visibility headwinds; management targets sequential growth in Q3 and Q4 and cites a record large-deal pipeline (>20 deals; >$500M ACV), positioning FY26 for acceleration.

What Went Well and What Went Wrong

What Went Well

• Adjusted diluted EPS up YoY/QoQ to $1.13; GAAP EPS above internal forecast driven by a one-time tax benefit and contingent consideration reversal; headcount ramp supports expected H2 growth. “EPS came in above forecast as a result of a one-time tax benefit” — Keshav Murugesh.
• Record large-deal pipeline (>20 deals; >$500M ACV) across verticals, with conversions expected to be spotty but supportive of FY26 acceleration. “More than 20 large deals representing over $500 million in annual contract value” — Keshav Murugesh.
• Strong analytics/AI capabilities embedded across offerings, recognized by industry analysts; standalone analytics growing ~20% CAGR over past 3 years; GenAI expected to contribute ~5% of FY25 revenue. “Stand-alone analytics was growing at a 20% CAGR… 5% target for Gen AI still good” — management.

What Went Wrong

• Top-line softness: revenue declined YoY and net revenue fell on both YoY and QoQ bases; adjusted operating margin compressed YoY (18.6% vs. 21.5%) with higher SG&A and lower utilization.
• Sector headwinds: OTA volumes pressured (now <4% of revenue in Q2) and loss of a large healthcare client; continued weakness in discretionary projects.
• Guidance cut: FY25 net revenue (less repair payments), ANI, and EPS reduced; large-deal revenue removed from guidance due to timing uncertainty, limiting near-term visibility.

Transcript

Operator (participant)

Good morning, and welcome to the WNS Holdings fiscal 2025 second quarter earnings conference call. At this time, all participants are in listen-only mode. After management prepared remarks, we will conduct a question-and-answer session, and instructions for how to ask a question will follow at that time. As a reminder, the call is being recorded for replay purposes. Now, I would like to turn the call over to David Mackey, WNS Executive Vice President of Finance and Head of Investor Relations. David?

David Mackey (EVP of Finance and Head of Investor Relations)

Thank you, and welcome to our fiscal 2025 second quarter earnings call. With me today on the call, I have WNS's CEO, Keshav Murugesh, and WNS's CFO, Arijit Sen. A press release detailing our financial results was issued earlier today. This release is also available on the investor relations section of our website at www.wns.com. Today's remarks will focus on the results for the fiscal second quarter, ended September 30th, 2024. Some of the matters that will be discussed on today's call are forward-looking. Please keep in mind that these forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Such risks and uncertainties include, but are not limited to, those factors set forth in the company's Form 20-F. This document is also available on the company website.

During this call, management will reference certain non-GAAP financial measures, which we believe provide useful information for investors. Reconciliations of these non-GAAP financial measures to GAAP results can be found in the press release issued earlier today. Some of the non-GAAP financial measures management will discuss are defined as follows: Net revenue is defined as revenue less repair payments. Adjusted operating margin is defined as operating margin, excluding amortization of intangible assets, share-based compensation, acquisition-related expenses or benefits, and impairment of goodwill and intangible assets. We are also excluding costs related to our ADS program termination and costs associated with the transition to voluntarily reporting on U.S. domestic issuer forms.

Adjusted net income (ANI), is defined as profit, excluding amortization of intangible assets, share-based compensation, acquisition-related expenses or benefits, goodwill and intangible asset impairment, ADS program termination costs, the transition to voluntarily reporting on U.S. domestic issuer forms, and all associated taxes. These terms will be used throughout the call. I would now like to turn the call over to WNS's CEO, Keshav Murugesh. Keshav?

Keshav Murugesh (CEO)

Hey, thank you, David. Good morning, everyone. WNS's second quarter revenue and margin were largely in line with company expectations, while EPS came in above forecast, based on one-time tax benefits of $9 million. The company posted net revenue of $310.7 million, representing a year-over-year decrease of 4.4% on a reported basis and 5.2% on a constant currency basis after adjusting for foreign exchange. Versus the previous quarter, net revenue decreased by 0.6% on a reported basis and by 1.5% on a constant currency basis.

Sequentially, the ramp of four large deals sold in fiscal Q4 of last year and broad-based demand for process automation and cost reduction initiatives in the first half of 2025 largely offset the loss of a large healthcare client and continued reductions in our online travel revenues. During the second quarter, we added nine new logos and expanded 41 existing relationships. For the full year, guidance has been lowered to reflect continued reductions in online travel volumes and slower than expected conversion of large deals. While the large deal pipeline continues to expand, the timing of these contract signings, as well as associated revenue ramps, is proving difficult to predict. As a result, at this time, we have removed the large deal revenue contribution from our fiscal 2025 guidance.

Currently, we have more than 20 large deals, representing over $500 million in annual contract value, spread across all key verticals, services, as well as geographies. We are making good progress moving these deals through the pipeline and remain confident that WNS is well positioned to win more than our fair share of these opportunities. For the past several quarters, we've been discussing how WNS is increasingly delivering outcomes for our clients at the intersection of domain, digital, as well as data. We continue to make strategic investments in all three of these areas, with a focus on developing proprietary technology tools and platforms, forging new strategic relationships, as well as reshaping our global talent. Today, I want to spend a little time highlighting our organizational capabilities and progress in our data, analytics, and AI practice.

At WNS, we believe the true power of analytics is realized when combined with technology, domain specialization, and process expertise. As a result, we are focused on ensuring that analytics and technology are integrated into everything we do, from customer, you know, CX solutions to end-to-end transformational engagements. Today, WNS boasts a mature, robust, and differentiated analytics practice that has been built over the past twenty years through a combination of organic investments as well as strategic acquisitions. At the core of our analytics practice is data management, which is the foundation for all analytics work, including AI as well as generative AI. WNS has built a strong portfolio of data management services and platforms that enable our clients to source, clean, organize, integrate, as well as secure their data to unlock its inherent value.

This includes expertise in converting unstructured data from sources like emails, images, text, audio, sensors, as well as social media posts, into structured data to create usable, analyzable constructs. Our strengths in optimizing data quality and managing data as an asset are critical to help deliver actionable insights as well as business outcomes. In addition, our strategic acquisitions over the past several years have helped turbocharge WNS's ability to combine analytics and technology to create reusable components, which underpin our services and solutions. These proprietary assets are stitched together with domain and process expertise, adding humans in the loop to create productized services across both horizontals and verticals. Our productized services enable WNS to accelerate speed to market and deploy our solutions at scale, while maintaining the flexibility to co-create customized, differentiated solutions for each of our clients.

To date, WNS has built AI-led analytics assets across all key horizontals, including finance and accounting, procurement, and supply chain, and customer support. The company has also created unique industry-specific capabilities, such as claims management and recovery services for insurance companies, R&D, and clinical specialization offerings for big pharma, revenue growth management services for retail and CPG firms, and a GenAI-led documentation platform for shipping and logistics. These offerings have enabled WNS analytics to attract some of the world's largest brands as clients, including industry leaders in beverages, biopharma, as well as restaurants. Within our data practice, we have also been investing in the expansion and enhancement of our front office, on-site centric consulting capabilities, and with the pace of change and technological advancement accelerating, clients are increasingly looking for experts to help them assess their current situations and help them co-create solutions.

Over the past two years, WNS has built a global analytics client solutions team of senior resources that is solely focused on helping clients achieve these objectives. These senior level consultants have data as well as domain specialist backgrounds, and are responsible for helping clients with their data, AI, and analytics requirements across strategies, gap analysis, roadmaps, change management, governance, and processes. The upfront consulting efforts help set the foundation for successful business transformation programs as well as value-driven relationships. As a result of these investments, WNS's analytics is experiencing strong growth despite the weak macro environment, with our standalone analytics work growing at a 20% CAGR over the past three years. And while standalone reported analytics today represents 14% of WNS revenue, it is safe to say that the majority of total company revenues now has analytics embedded as part of the client solution.

And all of the large deals in our pipeline have technology-enabled analytics as a critical component of our value proposition. WNS's solid growth and expanding capabilities in data, analytics, and AI are increasingly being recognized by the analyst and the advisor community. We've now been named a market leader by HFS in analytics, AI, data platforms, and automation services, a star performer for analytics business process services by Everest, and a leader in data science services by Analytics India Magazine, and an AI game changer by NASSCOM. The company also received seven Stevie Awards for its AI, machine learning, and GenAI solutions, and an AI Excellence Award from Business Intelligence Group for our GenAI capabilities. As the analysts and advisors remain important gatekeepers to many client initiatives, this positive recognition is critical to ensuring that WNS remains top of the mind for outsourcing opportunities.

In summary, by combining the power of data, digital, as well as domain, today, WNS is able to deliver impactful business outcomes for our clients, including generating actionable insights to improve decision-making, reducing business risk, enhancing customer experience, and enabling innovation and competitive differentiation. With respect to our fiscal 2025 guidance, while we remain comfortable in our ability to close some of the large opportunities, given their uncertain timing, we have removed the large deal revenue contribution from our updated projections. Guidance also assumes a further reduction in OTA revenues in the second half of the year based on current volume trends. And despite these challenges, we are comfortable in our ability to sequentially grow revenues in fiscal Q3 as well as Q4, providing solid momentum exiting the year.

Any second half large-scale large deal signings should provide some incremental revenue this year, but more importantly, will provide enhanced visibility to revenue acceleration in fiscal 2026. WNS remains committed to continuing our investments in domain expertise, data and analytics, and technology-enabled offerings, leveraging AI and GenAI, to ensure our ability to deliver long-term profitable growth and sustainable shareholder value. I would now like to turn the call over to our CFO, Arijit Sen, to further discuss our results as well as outlook. Arijit?

Arijit Sen (CFO)

Thank you, Keshav. In the fiscal second quarter, WNS's net revenue came in at $310.7 million, down 4.4% from $325 million posted in the same quarter of last year, and down 5.2% on a constant currency basis. Sequentially, net revenue decreased by 0.6% on a reported basis and 1.5% constant currency. The quarter-over-quarter revenue decline was driven by the loss of a large healthcare client, volume reductions in online travel, and ongoing weakness in discretionary project-based revenues. These revenue headwinds were partially offset by the ramp of a large deal closed in Q4 and healthy demand for digitization and cost reduction-focused initiatives. In fact, excluding the large healthcare client loss, each of our verticals posted sequential growth this quarter.

In Q2, WNS recorded $1.2 million of short-term, high-margin revenue. Adjusted operating margin in Q2 was 18.6%, as compared to 21.5% last year and 18.4% last quarter. Year-over-year adjusted operating margins decreased as a result of lower revenue and employee utilization, increased investments in infrastructure and sales, and higher SG&A levels, resulting from $2.1 million of expense provision reversals for performance incentives and bad debt in Q2 of last year. These headwinds were partially offset by favorable currency movements. Sequentially, margin improvement was driven by favorable currency movements.

The company's net other expense was $1.4 million of net expense in the second quarter, as compared to $0.1 million of net expense in Q2 of fiscal 2024, and $0.3 million of net expense last quarter. Both year-over-year and sequentially, the unfavorable variance is the result of higher debt levels and lower cash balances, driven primarily by our share repurchases. WNS's effective tax rate for Q2 came in at 8.5%, as compared to 22% last year and 23.1% in the prior quarter. The Q2 tax rate reduced by almost $9 million, primarily due to one-time tax benefits associated with the reversal of a deferred tax liability on income tax.

Both year-over-year and sequentially, other changes in the effective tax rate were driven by our geographical profit mix and the percentage of work delivered from tax incentive facilities. The company's adjusted net income for Q2 was $51.5 million, compared with $54.4 million in the same quarter of fiscal 2024, and $44 million last quarter. Adjusted diluted earnings were $1.13 per share in Q2, up from $1.10 in the second quarter of last year and from $0.93 last quarter. As of September 30, 2024, WNS's balances in cash and investments totaled $221.5 million, and the company had $262.8 million in debt.

In the second quarter, WNS generated $43.6 million of cash from operating activities, incurred $12.7 million in capital expenditures, and paid debt repayments of $43 million. The company also repurchased 1,156,000 shares of stock at an average price of $56.61, which impacted Q2 cash by $71.7 million. Through the first half of fiscal 2025, WNS has repurchased 2.8 million shares of stock at an average price of $53.46, and a total cost of $149.7 million. DSO in the second quarter came in at 38 days, as compared to 35 days reported in Q2 of last year and 36 days last quarter.

With respect to other key operating metrics, headcount at the end of second quarter was 62,951, and our attrition rate was 34%, as compared to 30% reported in Q2 of last year and 34% in the previous quarter. We expect attrition to average in the low- to mid-30% range, but the rates could remain volatile quarter to quarter. Built seat capacity at the end of Q2 increased to 43,108, and WNS averaged 72% work from office during the quarter. In our press release issued earlier today, WNS provided a revised full year guidance for fiscal 2025.

Based on the company's current visibility levels, we expect net revenue to be in the range of $1.25 billion to $1.296 billion, representing a year-over-year range of -3% to +1% on a reported basis. On a constant currency basis, the guidance range is from -4% to 0%. As Keshav mentioned, our fiscal 2025 guidance assumes no revenue contribution from the large deal pipeline, ongoing reductions in online travel volumes, and no improvement in discretionary project spend. Guidance also excludes short-term revenues and any incremental revenue from a large insurance captive. Top-line projections assume an average GBP to USD rate of 1.31 for the remainder of the fiscal year.

Full year adjusted net income for fiscal 2025 is expected to be in the range of $190 million-$200 million, based on an 83.5 INR to USD exchange for the remainder of fiscal 2025. This implies adjusted EPS of $4.13-$4.35, assuming a diluted share count of approximately 46 million shares. With respect to capital expenditures, WNS currently expects our requirements for fiscal 2025 to be up to $65 million. We will now open the call for questions. Operator?

Operator (participant)

Thank you. Ladies and gentlemen, if you wish to ask a question at this time, you will need to press star one one on your telephone and wait for your name to be announced. If your question has been answered or you wish to remove yourself from the queue, please press star one one again. In the interest of time and to enable everyone on the call to participate, please limit yourself to one question and one follow-up. Please stand by while we compile the Q&A roster. Our first question coming from the line of Nate Svensson with Deutsche Bank. Your line is open.

Nate Svensson (Analyst)

Hi, guys. Thanks for the question. I wanted to delve a little more into the large deal pipeline and win rates. So you had the four large deals in 4Q of last year, one large deal in 1Q. It sounds like none this quarter. At the same time, you need to talk about how the large deal pipeline is at record levels. So I'm just hoping for a little more clarity on the lower visibility called out versus maybe realizing lower win rates than what you've seen historically. Going through the comments from last quarter, I think you said that the large deal wins baked into the prior guide would imply up a low average win rate in the pipeline. So just trying to get a sense of how much the change in guide is being driven by general demand trends versus maybe increased pressure on the competitive or pricing side of things?

Keshav Murugesh (CEO)

Okay, I think I'll take that. So first of all, I must mention, you know, once again, want to underline the fact that the overall pipeline for sale continues to be very strong and at record levels across most of our businesses. You know, the impact that we spoke about for H2 is essentially because of what I would call the perfect strong storm around two or three specific areas that were called out in the prepared remarks. Actually, at this point in time, we continue to have a very strong pipeline of large deals and let me just explain how these things are progressing. Today, I would say that we have almost, you know, more than 25+, you know, large deals, which are 10 million+ in terms of, yeah, ACV. And many of these are very strategic in nature.

They need, you know, very strong involvement, both sides of the house, our side as well as the client side. And what happens in many of these deals, which we are now, you know, understanding better, is that as the client gets much more comfortable with who they're interacting with in WNS, what actually happens is their focus is built on the comfort around our understanding of their business domains very well. They definitely want to see much more attention from the top of the house, which means I need to be personally involved in many of these deals.

Many of these deals are focused not just on, you know, regular transformation or, you know, cost leadership for the client, but a lot of it is focused around revenue accretion, which means involvement of many more layers inside the, you know, the client side. Want to also mention that this also means, you know, it's a, a very strong partnership model between both sides, and it also means, in a positive way, that in many of these deals, we've been able to move the narrative away from procurement, which is very critical, you know, for WNS in terms of, you know, making sure that over a period of time, these ultimately result in a win-win, for both sides and not driven by a procurement approach to these programs.

All these deals in terms of size, complexity, as well as in the nature, are very, very strategic. And it also, by definition, means more involvement from an executive committee on the other side, often boards getting involved in the decision on the other side, board from WNS's side also getting involved in terms of taking some of these decisions. And I think that is the misstep that we made, you know, when we baked the, you know, some of this revenue into our guidance. If you look at how we actually have made progress, the number of deals, size of deals, and the volumes now being projected by some of these prospects are even higher than what we saw last time.

I mean, we just guided—we just mentioned that we have almost $500 million of ACV in some of these deals. But the reality is, it is taking a little longer, and, you know, we probably assumed that based on the fact that we signed some of those deals in fourth quarter or something in Q1, that the same progress and signings would continue in Q2. What we have only done at this point in time is been more conservative in terms of taking that revenue out of the potential pipeline for the rest of the year, because we understand that even when we close this during Q3 or Q4 or wherever, the potential for revenue during this year will be minimal, but potential for revenue in the next years will be high.

I want to end again by saying these deals are very, very critical for WNS. They're changing the game for us for the long term, and we believe super confident about the fact that the $1 million-$3 million deals that we're continuously winning, as well as some of these deals as they win, will, you know, build tremendous comfort, confidence, in terms of long term, and some of it is also being reflected in terms of the headcount that you may have seen on our books.

David Mackey (EVP of Finance and Head of Investor Relations)

Just to add to that real quick, Nate, I think the other thing to touch specifically on the question you asked about win rate, the removal of the large deal pipeline has nothing to do with win rate, right? I think we still believe we're extremely well positioned in these opportunities. I think the removal of the large deal pipeline is about timing and not relative to our expectations about the number of deals that we can win or how we're positioned within these deals.

Nate Svensson (Analyst)

Yeah, that's great to hear on the win rates, and I think it was a prudent thing to take those out of the guide. So, that's appreciated. I guess for the follow-up, maybe taking a step back, when I think about the history of WNS, you've obviously been able to differentiate yourself with history of strong execution, consistent double-digit organic growth, and then being able to set expectations so that you can kind of beat and raise as you move to the fiscal year. Obviously, we're in the midst of a really weak macro and still a lot of uncertainty out there.

But maybe taking a step back, you touched on this in your last answer, but maybe can you talk a little bit more about your confidence in your ability to return to that historical growth profile and execution as we move into fiscal 2026 and beyond? I think last call, you mentioned that you were well set up for next fiscal year, but obviously a ton of puts and takes impacting the business right now. So I think it would just be helpful to hear your thoughts on the business's ability to get back to that strength you've demonstrated historically.

Keshav Murugesh (CEO)

Yeah. Again, you know, we are super confident about our ability to get back to strong growth rates. Once again, I must mention that what we have experienced this year are very specific client related or specific issues that we have had to call out for this year. Nothing to do with the demand trends, nothing to do with the tailwinds we are seeing in the industry. In fact, we would expect that with all the uncertainty being seen outside, we would only benefit being one of the legacy players and transformational, you know, kind of players in the industry. Again, I must mention that most clients are looking for, you know, partners who come in with very strong understanding of digital data and domain that we spoke about.

But most of the deals are also being led by technology, analytics, AI, in some cases, generative AI as well. All areas that WNS has traditionally invested in and continues to invest, you know, very strongly in. Again, I must say that we have already got a lot of confidence in terms of revenue momentum for Q3 as well as Q4 coming back, right, in terms of sequential growth. And as we win some of these other deals, the large deals, as well as the traditional bread and butter, $1 million-$3 million or $1 million-$5 million deals, we believe that we are at probably among the at the lowest end of, or the worst, or the worst is now behind us in terms of where we could be. You know, the future state is one of solid growth as well as profitability.

David Mackey (EVP of Finance and Head of Investor Relations)

Yeah. And to, and just to add a little color to that, Nate, I think, you know, as, as was mentioned in the prepared remarks, the underlying growth in Q2 was extremely healthy. I mean, if you take out the large healthcare client loss, we, we grew in excess of 3% sequentially in Q2. The guidance, despite removing the large deal pipelines, you know, we're, we're looking at $320 million in Q3, which represents a 3% sequential growth from Q2. And obviously, if you do the math to, to what's left for Q4, you're looking at a 2%-3% sequential growth from Q3 to Q4. So the confidence in returning to double growth, double-digit growth comes from the 3% sequential growth rate that we're now posting, despite not having the momentum from the large deal pipeline.

Nate Svensson (Analyst)

I appreciate the color, and good to hear about the long-term confidence. Thank you.

David Mackey (EVP of Finance and Head of Investor Relations)

Thanks, Nate.

Operator (participant)

Thank you. Our next question coming from the line of Bryan Bergin with TD Cowen. Bryan, your line is open.

Bryan Bergin (Analyst)

Hi, thanks for taking the question. Can you comment on the OTA side of the equation here? Just how much was this pressure a result of some of the guidance reduction as well?

David Mackey (EVP of Finance and Head of Investor Relations)

Sure. So let me take that. When you look at the guidance reduction for the full year, we're looking at about a 1%-2% impact from the Q2 reduction in OTA and our expectation of continued volume reductions in the back half of the year. So again, I think we've been. We've tried to be conservative here about our expectations for the sector, and we've discussed, you know, at length over the last several quarters, the reasons for the challenges that we've had in the OTA sector, you know, whether that's automation, whether that's strategy change, whether that's customer-specific challenges within the OTA space, and their inability to forecast their volumes and predict accordingly.

So, you know, I think we've taken a very conservative approach to the OTA space, but I also wanna reiterate some of the messages that we brought last quarter, which is that if we can't be impactful to the client, if we can't create value for the customer, and if the client's not willing to recognize the value that we're delivering, then that's not a business that we want to be in, right? So we're not gonna play in low-end commoditized types of work, and, you know, if the client's taking a commoditized view of these services and solutions, then we're going to be getting out of it.

Keshav Murugesh (CEO)

Yeah, but I must just add one element there, Dave, which is, while, you know, that is our stated objective, and we are having lots of interesting discussions with the client and the, you know, clients in the sector generally, we also realize that all of them are also understanding that, you know, business model transformation for themselves also is going to be critical in order to survive the onslaught of what's happening in the market for them long term.

Therefore, I must say, there are also lots of healthy discussions happening between both sides in terms of things that we can do for them that go well beyond some of the traditional services that may have got, you know, commoditized and which we are walking away from, but allows us to bring the rest of the power of WNS in, in terms of digital data, domain, analytics, and take them into higher value, you know, kind of services, and so we'll have to watch the space in terms of how that develops.

Bryan Bergin (Analyst)

Yeah, okay.

David Mackey (EVP of Finance and Head of Investor Relations)

Suffice to say, Bryan, that our OTA revenues in the second quarter were now below 4% of total company.

Bryan Bergin (Analyst)

Okay. Okay. And then, as it relates to the... just the headcount growth sequentially, can you just comment where are you seeing that growth? What's attributing to that expansion?

Arijit Sen (CFO)

Yeah, so let me take that, this is Arjit. So look, I think Dave talked about it. You know, if you back out the large healthcare client loss, you know, you'll see that there is growth that's coming in Q2. Our guidance also implies a 2%-3% sequential growth year on year. So the hiring for that growth, we already started hiring, and the headcount increase actually cements our, you know, view of the pipeline and the growth momentum that we are actually trying to see in Q3 and Q4. So next, you know, we've already started the hiring. You know, we are expecting the increase in revenue to happen in Q3 and Q4. And, you know, our business requires us to hire 90 to 120 days in advance for us to ramp and train the employees. That some of that is bearing in the higher headcount numbers that you are seeing in Q2.

David Mackey (EVP of Finance and Head of Investor Relations)

I think the other thing that's embedded, and Arjit touched on it a little bit, is, if you'll recall, the large healthcare client that we lost, what was a technology-heavy service offering, right? So when you look at kind of how that works its ways through our sectors and things like that, what you'll see is that while it was very high revenue for us, the number of employees supporting that service offering were relatively low. So part of what you've seen here is that as we replace the healthcare lost client revenue with more traditional types of WNS revenues, it's going to take more people to backfill that headcount.

Bryan Bergin (Analyst)

Got it. Okay, thank you.

Operator (participant)

Thank you. And our next question coming from the line of Mayank Tandon with Needham & Company. Your line is open.

Mayank Tandon (Analyst)

Thank you. Good morning, Keshav and Dave. I wanted to just get a better grasp on the headwinds that you called out. Could you just walk through the timing when these headwinds will start to abate? In other words, when do we get to a model when it's a clean slate, and we can see that growth start to show up, especially as these big deals start to ramp up, potentially in a few quarters based on some of your comments?

David Mackey (EVP of Finance and Head of Investor Relations)

Yeah, look, I think we've talked about, in general, I mean, three meaningful headwinds, right? Over the last year and a half. One is the large healthcare client loss, one is the shift from onsite to offshore of one of our large internet-based clients, and the other has been the OTA volumes. Obviously, this quarter was the ramp down of the large healthcare client. So, I guess, depending on whether you're looking at this on a sequential basis or a year-over-year basis, we can have different discussions about kind of the headwinds. But on a sequential basis, at any rate, you know, the vast majority of this will have abated by Q3. So, you know, we don't have a sequential impact from Q2 through Q3 from the large healthcare client.

We don't have a sequential impact from Q2 to Q3 from the internet client moving offshore, and we have a modest expected headwind within the OTA volumes.

Mayank Tandon (Analyst)

Got it. That clears it up. And then just as a follow-up, I wanted to ask about margin expectations. What is embedded in the guide in the back half? Maybe you could walk through gross margins and the operating margins. Just trying to get a sense if you're going to be a little bit more fixated on expense management in the face of maybe the slower ramp of those larger deals. Just any color on the margin trajectory in the back half, and your expectations to get back to that low twenties EBIT margin longer term as revenue starts to come through.

David Mackey (EVP of Finance and Head of Investor Relations)

Yeah, I think, Mayank, our expectation is that we're going to get back into the low twenties by the fourth quarter, and that we will see margin expansion on the adjusted operating margin line in both Q3 and Q4. We're probably looking in the 19%-20% range for adjusted operating margins for the full year. And that's really at the end of the day because we've removed the revenues associated with the large deals. But the investments that we've made in the business, whether that's into, you know, expanding our capabilities or building out our infrastructure, which we need to continue to do, we're not going to scale back on that. The bottom line is, you know, we believe in the long-term health. We see the momentum in the business. We need to be planning for the future.

So those investments are not going to be scaled back. The infrastructure spend and the build of our global capability is not going to be scaled back. And if you look at the real reason that we've got a little bit of margin pressure on a year-over-year basis, it's an expense coverage issue. At the end of the day, our SG&A rate is going to run a little bit higher this year because it doesn't make sense to take those numbers down for two quarters and then build them back up, starting in the first quarter of next fiscal. So, at this point in time, you know, we are going to see steady margin expansion through the back half of the year, but the reality is the full year margins are going to be a little bit below where we were last year.

Keshav Murugesh (CEO)

Yeah, Mayank-

Mayank Tandon (Analyst)

Go ahead.

Keshav Murugesh (CEO)

In fact, I just mention one thing. This is now all about growth and not just about margin now. Our focus now is we believe that the worst is now going to be behind us, you know, over the next few weeks, months, quarters, based on all that we have announced. We believe that we have a very, very strong pipeline. We believe that we have to come back in terms of overall growth rates, and that's where, you know, we are focused and are investing in. And we are confident that these investments that we are making in all the core areas, including sales and marketing, will help us close deals and come back to the growth rates that we have traditionally delivered to the market.

Arijit Sen (CFO)

Just to add to the other question on gross margins, if you see our gross margins, our gross margin is actually fairly flat versus last year. That gives us confidence that our underlying business continues to remain profitable while we continue to invest in some of the sales investments that Dave and Keshav talked about. Fundamentally, business continues to be profitable. We have invested in our sales and marketing, and as the growth comes back, operating margin will also improve.

Mayank Tandon (Analyst)

That's a great color. Thank you, all.

David Mackey (EVP of Finance and Head of Investor Relations)

Thanks, Mayank.

Keshav Murugesh (CEO)

Thank you, Mayank.

Operator (participant)

Thank you. And our next question coming from the line of Puneet Jain with JPMorgan. Your line is open.

Puneet Jain (Analyst)

Yes, hi. Thanks for taking my question. Keshav, could you double-click on clients' behavior as it relates to incorporating AI or analytics in their processes? Is their behavior different across new versus existing clients, or are there any verticals where you're seeing demand stronger than others? And also you previously mentioned generating 5% of revenue from GenAI this year. Is that still on track, given some of, like, the large deal contribution it seems like have been pushed out?

Keshav Murugesh (CEO)

Yeah, Puneet, that's an excellent question. So, you know, just in terms of behavior, as you would expect, based on the stress a client is facing or the opportunity that they're seeing in the market, you know, the different verticals obviously are behaving slightly, you know, differently. You know, we spent a lot of time talking about OTA and things like that, and, you know, I don't want to go down that path of explaining that. But generally, if you look at it, everyone has understood very well that companies like, like WNS understand the domain side very well, has invested so much in, you know, digital and analytics. And, you know, AI has been around for a while.

Our ability to incisively use AI to deliver better outcomes for our clients has now got accelerated or enabled, I would say, over the last possibly eighteen months or so, because there's much greater belief in that model. Generative AI is something that everyone understands, you know, can be something that can make, you know, client models much smarter, can help them with their cost challenges, can help them with their transformation agenda.

And therefore, over the past, you know, so many quarters, our focus has been on, first, educating clients about how we can help them with this model, about how they don't have to invest in licenses, in order to, you know, get the benefits of some of these models, and then over a period of time, help them pinpoint which are the processes that, you know, could actually benefit from some of these, business model changes for them. So I think, I think at this point in time, what we're seeing is people now realize that this is one more change in technology and model that is going to help them in terms of transformation, transforming their agenda, being more relevant to their end customers, doing things smarter, better, faster, you know, more impactful manner, so to speak.

And therefore, to do that, as a client, you need to work with a provider or a partner who really is an extension of your enterprise, who understands your domain, understands your history, understands your strategy, understands where, you know, you want to be over a period of time, and what are the growth levers for you. And that is where WNS, you know, scores each and every time, right? So first and foremost, I will say that that is a, you know, a huge advantage that we have because of the sheer knowledge of our customers' businesses, the core verticals, the transformation agenda, and our points of view on how different models are changing, right? That's the first thing. The second thing is, you know, we spoke about generative AI.

We are now very focused after educating many of these customers in terms of leading them down specific paths now, right? To help them understand that these, you know, offerings that we bring to the table will make them not only more efficient but also help transform their business models. So what's actually happening is, it is allowing them to focus much more on the external, while allowing us to manage the rest for them.

Coming to large deals, obviously, when you interact with a new customer and you're looking at a completely different business model, where you moved away from procurement and interacting at the top of the house on the other side, when you go into this discussion, you bring all the armory that you have, you know, to the fore in order to create a transformed business model, as a result of which it's a CEO-led initiative, both sides. And therefore, all the, you know, kind of, engines that we bring to the table are really, available up front and center in terms of some of these new deals. At the same time, this thinking is also going into expansion within our existing clients.

You know, one can see that while the earlier processes took a little longer, at this point in time, expansions around existing clients is all being focused on leveraging some of these models. And any of the large deals now have a combination of all of this up front and center. And that's the reason why probably some of these closures take a little longer, because it means significant amount of disruption even for the client, right? Acceptance of this disruption and change, validating all the assumptions and making sure that it's a handshake at the top of the house between WNS and the client, right? So it's a significant change, and we expect, therefore, that as we start winning some of these models, this will be the model of the future that will drive WNS's growth momentum for the long term.

Puneet Jain (Analyst)

Got it. And is 5% still, like, a reachable target?

David Mackey (EVP of Finance and Head of Investor Relations)

Yeah, I think it absolutely is. As Keshav mentioned, you know, the GenAI revenues and the implementations are not specific to just new initiatives, while it's certainly a part of almost all of the new initiatives, and I would say all of the new initiatives. A lot of what we're doing with GenAI is expansion opportunities within our existing customer base and changing how we're operating within some of our existing customers. So, you know, that contribution is not all just kind of gross growth. It's also changing some of what we're doing for existing clients as well and delivering enhanced value to those customers. So I think that 5% target for the year is still good.

Puneet Jain (Analyst)

Got it. And then, Dave, like, you were very helpful in identifying, like, the three issues and sharing, like, the timing of those. As we think about next year, like, can you quantify, like, the year-on-year impact we should expect from those three headwinds or any other puts and takes that we should consider for next year? I can imagine, like, these headwinds will still have impact on year-on-year basis in the first half of next year, so-

David Mackey (EVP of Finance and Head of Investor Relations)

Yeah. Yeah, look, I mean, I think the simple math, Puneet, is we know that the healthcare client is gonna impact three of the four quarters for this year. So we have one quarter of impact next fiscal year, so you can expect roughly 1% on a year-over-year basis from the large healthcare client. The OTA space for the full year is gonna end up costing us around 3%-3.5% of revenue. So if you just take a mid-year convention for that, I think you're looking at roughly 1.5%-2% for next year. So you're looking at a 3% lag, if you will, from the ramp downs in this fiscal that bleed into fiscal 2026.

Puneet Jain (Analyst)

Is there any other headwind that we should consider as we think about next year?

David Mackey (EVP of Finance and Head of Investor Relations)

Not, not at this time.

Puneet Jain (Analyst)

Okay.

David Mackey (EVP of Finance and Head of Investor Relations)

Before I say not at this time, other than the standard headwinds that we have in our business around productivity and projects and expectations of known ramp downs. So I think, you know, that normal 10%-11% is still in play.

Puneet Jain (Analyst)

Yes, of course. Yes.

David Mackey (EVP of Finance and Head of Investor Relations)

Yeah.

Puneet Jain (Analyst)

I meant, like, any other unusual headwinds, so thanks for clarifying.

David Mackey (EVP of Finance and Head of Investor Relations)

No.

Puneet Jain (Analyst)

Appreciate it.

David Mackey (EVP of Finance and Head of Investor Relations)

No.

Operator (participant)

Thank you. And our next question coming from the line of Maggie Nolan with William Blair. Your line is open.

Jesse Wilson (Analyst)

Hi, guys. This is Jesse Wilson on for Maggie. Thanks for taking our questions. So I understand your comments on visibility. So maybe can you take a step back and reflect on how you feel about some of the changes you've made in the sales force? How long do you think it'll take some of these leaders to ramp up? And is the new model pulling you into conversations with a wider range of C-suite execs?

David Mackey (EVP of Finance and Head of Investor Relations)

Yeah, let me take this, and then Keshav can kinda add some color here. But, yeah, I think our expectations around the contributions from these senior-level sales resources that we've hired, the chief growth officers across all of our verticals, are being largely met, right? I think that's, you know, this is how that large deal pipeline has been curated, you know, to have 20+ deals with 500 million+ of ACV is something that we're extremely excited about. You know, it's the timing and the closure that becomes an issue, but, you know, we've built that pipeline over the last 18 months. I think we remain well-positioned in a lot of those opportunities. They're doing what they're supposed to do.

They're getting Keshav involved in these deals where he needs to be involved, where we need that, you know, CEO to CEO connect. And we still feel good about the investments that we've made into this, into this new channel and, and the progress that we've made. You know, obviously, we would love to have signed, you know, three more large deals this quarter and, you know, have not had to adjust guidance. But we also, I think, recognize that given the size, given the complexity of, and, and the scope of these deals, that they're gonna be spotty, right? That, that it's gonna be, you know, three in one quarter and nothing for two quarters. And we just don't have a lot of control over that. We don't have a lot of visibility to when they're gonna hit.

But I think, as long as we keep moving them through the pipeline the way we have and connecting with the client at the right levels, we feel good about our ability to win more than our fair share of these opportunities.

Keshav Murugesh (CEO)

Yeah, and I'll just mention that the pressure on performance with our sales team is very, very high, and I think the tenure of these people is more than 12 months at this point in time. So our focus really is on the productivity of these people, monitoring constantly, making sure that they are educated in terms of the pivot that is taking place at the company in terms of data, digital domain and transformation, and they're being able to engage prospects and clients with the right, you know, conversations. So at this point in time, we believe that almost, you know, 65%-70% of the sales force is actually productive in the sense that we want them to be at. And normally in sales, anything above 50% or 60% is actually a decent track record, and I mentioned that as well.

But at the same time, because we want to make sure that our people are constantly, you know, filling the pipeline with those $1 million-$5 million deals... Look, I want to also once again underline, large deal, deals alone does not a company make, right? We need to constantly fill the pipeline with the bread-and-butter deals, which are $1 million-$5 million, and many of this, over a period of time, become large deals and large relationships for us. So our focus, in terms of making sure we have the right people bringing those deals and the rest of the people focusing on the large deals, is very intense. I think we have the right energy behind it. There's a huge excitement in the company in terms of what's happening there.

There's great excitement in the company in terms of the new capabilities that are being built, how these deals are, you know, being caught in terms of global delivery locations, and you know, how all of this together is creating magic for the company.

Jesse Wilson (Analyst)

Got it. I understand. That's helpful. For my follow-up, I saw in guidance that share count is higher by, I think, 100,000 shares from last time. So how much do you have left under the share repurchase program, and how come that ticked up by 0.1 million?

Keshav Murugesh (CEO)

Yeah, I think so-

David Mackey (EVP of Finance and Head of Investor Relations)

I'm sorry. Go ahead. Go ahead, Arijit.

Keshav Murugesh (CEO)

No, go ahead. Go ahead, Dave.

David Mackey (EVP of Finance and Head of Investor Relations)

Oh, no.

Arijit Sen (CFO)

Okay. So yeah, so it's coming slightly higher because we've had some exercises in the last quarter. But we have a pool of repurchase left. You know, at this point in time, you know, we are looking at using our capital for the strategic growth augmentation of some of the capabilities that Keshav talked about. You know, we are also looking at strategic M&A opportunities. But at the end of the fiscal, right, if we are not able to find effective utilization of this cash, you know, we might consider doing an aggressive repurchase. But at this point, the focus is driving more towards strategic growth.

David Mackey (EVP of Finance and Head of Investor Relations)

Yeah, and just to kind of close the loop on the numbers, you know, we've repurchased 2.8 million shares in the first half of the year, which is obviously quite aggressive. We have another 1.3 million left on the authorization that was done back in May.

Jesse Wilson (Analyst)

Got it. Thank you, all.

David Mackey (EVP of Finance and Head of Investor Relations)

Thanks.

Keshav Murugesh (CEO)

Thank you very much.

Operator (participant)

Thank you. And at this time, we have no further questions in the Q&A queue. This will conclude today's conference call. Thank you all for your participation, and you may now disconnect.